Oppenheimer Asset Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-36,669
Closed -$1.17M 1167
2023
Q3
$1.17M Sell
36,669
-1,626
-4% -$62.6K 0.02% 651
2023
Q2
$1.68M Sell
38,295
-2,192
-5% -$101K 0.02% 558
2023
Q1
$1.79M Buy
40,487
+564
+1% +$24.9K 0.03% 528
2022
Q4
$1.59M Sell
39,923
-6,324
-14% -$263K 0.03% 542
2022
Q3
$2.13M Sell
46,247
-3,617
-7% -$177K 0.04% 436
2022
Q2
$2.15M Buy
49,864
+755
+2% +$34.5K 0.04% 448
2022
Q1
$2.65M Sell
49,109
-273
-0.6% -$13.9K 0.04% 444
2021
Q4
$2.96M Sell
49,382
-2,546
-5% -$158K 0.04% 436
2021
Q3
$3.4M Sell
51,928
-3,681
-7% -$239K 0.05% 380
2021
Q2
$3.51M Sell
55,609
-2,568
-4% -$148K 0.05% 372
2021
Q1
$2.84M Buy
58,177
+3,224
+6% +$155K 0.04% 419
2020
Q4
$2.27M Buy
54,953
+4,736
+9% +$217K 0.04% 451
2020
Q3
$2.31M Buy
50,217
+3,942
+9% +$183K 0.04% 397
2020
Q2
$2.02M Buy
46,275
+12,988
+39% +$584K 0.04% 395
2020
Q1
$1.32M Buy
33,287
+5,206
+19% +$233K 0.03% 457
2019
Q4
$1.32M Buy
28,081
+21,947
+358% +$850K 0.03% 553
2019
Q3
$216K Buy
6,134
+1,832
+43% +$63.5K ﹤0.01% 1019
2019
Q2
$168K Sell
4,302
-171
-4% -$6.89K ﹤0.01% 1086
2019
Q1
$198K Sell
4,473
-330
-7% -$12.6K ﹤0.01% 1043
2018
Q4
$168K Buy
+4,803
New +$152K ﹤0.01% 1054

Other funds holding KIDS

Oppenheimer Asset Management's KIDS Position: Q4 2023 in Review

Oppenheimer Asset Management sold out of OrthoPediatrics (KIDS) in Q4 2023, closing a stake of 36,669 shares — an estimated $1.17M sold.

Oppenheimer Asset Management first reported a position in KIDS in Q4 2018 and held it in 20 quarters. The position peaked at $3.51M in Q2 2021. 129 funds tracked by Wall St. Rank hold KIDS as of Q4 2023.

  • Oppenheimer Asset Management reported no remaining OrthoPediatrics position as of Q4 2023 after selling out during the quarter.
  • Oppenheimer Asset Management sold 36,669 OrthoPediatrics shares in Q4 2023, an estimated $1.17M.
  • Oppenheimer Asset Management first reported a position in OrthoPediatrics in Q4 2018 and held it in 20 quarters.
  • Oppenheimer Asset Management's OrthoPediatrics position peaked at $3.51M in Q2 2021.
  • 129 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2023.

Based on Oppenheimer Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.